Vertex Pharma’s vision for reimbursement innovation

As regional vice president for Northern Europe & Australia, Simon Lem led the digital launch of Vertex Pharma’s novel cystic fibrosis drug Kaftrio.

Moderna broadens R&D scope with Vertex, Chiesi alliances

All eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotec

Celebrations as NHS England agrees deal for Vertex’ cystic f...

NHS England has agreed a deal with Vertex for its three-drug cystic fibrosis therapy Kaftrio, just days after the EMA’s human medicines committee recommended approval of the dr

As CHMP backs Vertex’ CF triple, campaigners plead for speed...

Cystic fibrosis patient groups in the UK are celebrating a recommendation by the EMA’s human medicines committee to approve Vertex' three-drug therapy Kaftrio – but fear anothe

CRISPR trials yield encouraging data in blood disorders

Vertex gets early okay for cystic fibrosis triple Trikafta i...